Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-23-000237

← back to feed
Filed
Aug 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q2 2023 · Jun 30, 2023 $16.46K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $22.06K
Current Liabilities Q2 2023 · Jun 30, 2023 $448.07K
Current Liabilities Q2 2023 · Dec 31, 2022 $433.65K
Total Liabilities Q2 2023 · Jun 30, 2023 $448.07K
Total Liabilities Q2 2023 · Dec 31, 2022 $433.65K
Current Assets Q2 2023 · Jun 30, 2023 $16.46K
Current Assets Q2 2023 · Dec 31, 2022 $22.06K
Total Assets Q2 2023 · Jun 30, 2023 $16.46K
Total Assets Q2 2023 · Dec 31, 2022 $22.06K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$7.61K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$391.59K
Stockholders Equity Q2 2023 · Mar 31, 2022 −$383.33K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$369.13K
Sga Expense Q2 2023 · Jun 30, 2022 $2.85K
Sga Expense Q2 2023 · Jun 30, 2022 $11.96K
Net Income Q2 2023 · Jun 30, 2022 −$8.26K
Net Income Q2 2023 · Jun 30, 2022 −$22.46K
Net Income Q2 2023 · Mar 31, 2022 −$14.2K
Operating Income Q2 2023 · Jun 30, 2022 −$2.85K
Operating Income Q2 2023 · Jun 30, 2022 −$11.96K